EPITHELIOID MESOTHELIOMA
Clinical trials for EPITHELIOID MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new EPITHELIOID MESOTHELIOMA trials appear
Sign up with your email to follow new studies for EPITHELIOID MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo therapy for mesothelioma shows early feasibility
Disease control OngoingThis early-phase trial tested whether adding the immunotherapy drug atezolizumab to standard chemotherapy before and after surgery is safe and feasible for people with resectable pleural mesothelioma. 28 participants received the combination, followed by surgery and possibly radi…
Matched conditions: EPITHELIOID MESOTHELIOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 12:02 UTC
-
Promising drug cocktail targets tough mesothelioma
Disease control OngoingThis study tests whether adding the drug cediranib to standard chemotherapy (cisplatin and pemetrexed) can help people with malignant pleural mesothelioma, a rare and aggressive cancer of the lung lining. About 117 participants who have not had prior treatment will receive either…
Matched conditions: EPITHELIOID MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:07 UTC